Targeting CDK4/6 in mantle cell lymphoma
Christina Y. Lee(Memorial Sloan Kettering Cancer Center), Selina Chen‐Kiang(NewYork–Presbyterian Hospital), Peter Martin(Northwestern University), Xiangao Huang(Cornell University), Maurizio Di Liberto(Howard Hughes Medical Institute)
Cited by 19
Related Papers
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2013|1.7k
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
|New England Journal of Medicine|2014|1.1k
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
|Leukemia|2009|877